September 23, 2014 5:48 AM ET

Biotechnology

Company Overview of Clingenix, Inc.

Company Overview

Clingenix, Inc. is a biotechnology company focusing on development and clinical validation of novel molecular diagnostics such as molecular screens for insulin resistance (IR). The company was founded in 1998 and is based in Sunnyvale, California with additional offices in China and Taiwan.

1308 Borregas Avenue

Sunnyvale, CA 94089

United States

Founded in 1998

Phone:

408-752-1635

Fax:

408-752-0347

Key Executives for Clingenix, Inc.

Co-Founder and Scientific Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
AquaGene, Inc. United States
Adlyfe Inc. United States
iDiverse, Inc. United States
MDxHealth, Inc United States
Stonybrook Technology and Applied Research (STAR), Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Clingenix, Inc., please visit www.clingenix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.